Global Exporter & Bulk Supplier of Flulieva 10mg Injection

🌍 Introduction

Are you searching for a certified and reliable global exporter for Flulieva 10mg Injection? At Ernest Oncology (the premier oncology division of Ernest Pharmaceutical Pvt. Ltd.), we specialize in the international distribution of high-quality antineoplastic agents. We provide streamlined supply chain solutions for Fludarabine 10mg injections to hospitals, hematology centers, and pharmaceutical wholesalers in the USA, UK, Australia, and South Africa.

🔬 1. Product Overview: Flulieva 10mg Injection

Flulieva 10mg Injection contains Fludarabine Phosphate, a potent fluorinated nucleotide analog of the antiviral agent vidarabine. It is a cornerstone in the treatment of various hematological malignancies.

• Composition: Fludarabine Phosphate 10mg (as a sterile lyophilized powder or solution)

• Therapeutic Class: Antineoplastic / Antimetabolite (Purine Analog)

• Formulation Type: Single-dose vial for intravenous (IV) infusion.

• Storage: Store at controlled room temperature ($20^\circ\text{C}$ to $25^\circ\text{C}$).

⚙️ 2. Mechanism of Action

Flulieva works by selectively inhibiting the DNA synthesis of rapidly dividing leukemic cells:

• Metabolic Activation: Fludarabine is rapidly dephosphorylated to 2-fluoro-ara-A and then phosphorylated intracellularly into its active triphosphate form (2-fluoro-ara-ATP).

• Enzyme Inhibition: It inhibits key enzymes such as DNA polymerase alpha, ribonucleotide reductase, and DNA primase.

• Chain Termination: Once incorporated into the DNA, it acts as a chain terminator, effectively halting the replication and repair of cancer cell DNA.

• Apoptosis Induction: This process triggers programmed cell death (apoptosis) in malignant lymphocytes.

🏥 3. Therapeutic Indications

Flulieva 10mg Injection is clinically indicated for:

• Chronic Lymphocytic Leukemia (CLL): Specifically for patients who have not responded to or have progressed during treatment with at least one standard alkylating agent-containing regimen.

• Non-Hodgkin’s Lymphoma (NHL): Often used in low-grade or indolent lymphomas.

• Acute Myeloid Leukemia (AML): Occasionally used in combination with other agents for refractory or relapsed cases.

• Conditioning Regimens: Utilized as part of the conditioning process prior to allogeneic hematopoietic stem cell transplantation.

⚠️ 4. Administration & Safety Guidelines

• Professional Use Only: Must be administered only via Intravenous (IV) Infusion by medical professionals experienced in cancer chemotherapy.

• Neurotoxicity Risk: High doses are associated with severe neurologic effects; adherence to the 10mg dosing protocol is critical.

• Hematologic Monitoring: Patients require frequent complete blood counts (CBC) due to the risk of bone marrow suppression (anemia, neutropenia, thrombocytopenia).

• Infection Risk: Fludarabine is highly immunosuppressive; patients should be monitored for opportunistic infections.